【摘要】 目的探讨早中期慢性乙型重型肝炎治疗应用中西医联合方案的临床效果。方法本文收集2013年10月-2016年10月期间于我院进行治疗的早中期慢性乙型重型肝炎患者82例做对比研究,以用药方案为依据,应用抛硬币的方式,将82例患者分为对照组(n=46例)和观察组(n=36例),两组均给予患者西医治疗方案,而观察组加用中医治疗方案,统计分析两组研究数据,探讨中西医联合治疗方案的临床应用价值。结果观察组总疗效91.67%显著高于对照组60.87%(P<0.05);治疗前,两组AST、ALT、TBiL、PTA指标水平对比(P>0.05),治疗后,两组AST、ALT、TBiL指标水平均低于治疗前(P<0.05),PTA指标均高于治疗前(P<0.05),组间治疗后对比,观察组各项指标改善情况优于对照组(P<0.05)。结论临床上针对早中期慢性乙型重型肝炎患者于西医治疗的基础上,应用中医治疗,疗效确切,可有效改善患者肝功能,具有较高的临床应用价值。更多还原

【Abstract】 Objective To investigate the clinical effect of combined traditional Chinese and Western medicine in the treatment of chronic severe hepatitis B in the early and middle stage. Methods Application of the toss of a coin, 82 patients were divided into control group(n=46 cases) and observation group(n=36 cases), two groups were given treatment with western medicine, while the observation group added with TCM treatment, statistical analysis of two groups of data, to explore the combination of Chinese and Western therapy clinical application value. Results The total effect of the 91.67% groups was significantly higher than the control group 60.87%(P<0.05) before treatment, two groups of AST, ALT, TBiL, PTA index(P>0.05), the level of comparison after treatment, two groups of AST, ALT, TBiL levels were lower than those before treatment(P<0.05).Conclusion On the basis of Western medicine treatment for patients with chronic severe hepatitis B in the early and middle stage, can effectively improve the liver function of patients with high clinical value.更多还原